Fragment-based drug discovery (FBDD) has become a powerful method for identifying new drug candidates. BOC Sciences has extensive capabilities in fragment-based drug discovery, and our experienced synthetic, pharmaceutical and computational chemistry teams provide expertise in screening, structural biology, as well as computational and pharmaceutical chemistry. We can effectively support your pharmaceutical chemistry project and support the development of your hot molecules into clinical drug candidates.